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Abstract: Wastewater-based epidemiology has become an important tool for the surveillance of 
SARS-CoV-2 outbreaks. However, the detection of viruses in sewage is challenging and to date there 
is no standard method available which has been validated for the sensitive detection of SARS-CoV-
2. In this paper, we describe a simple concentration method based on polyethylene glycol (PEG) 
precipitation, followed by RNA extraction and a one-step quantitative reverse transcription PCR 
(qRT-PCR) for viral detection in wastewater. PEG-based concentration of viruses is a simple proce-
dure which is not limited by the availability of expensive equipment and has reduced risk of dis-
ruption to consumable supply chains. The concentration and RNA extraction steps enable 900–
1500× concentration of wastewater samples and sufficiently eliminates the majority of organic mat-
ter, which could inhibit the subsequent qRT-PCR assay. Due to the high variation in the physico-
chemical properties of wastewater samples, we recommend the use of process control viruses to 
determine the efficiency of each step. This procedure enables the concentration and the extraction 
the DNA/RNA of different viruses and hence can be used for the surveillance of different viral tar-
gets for the comprehensive assessment of viral diseases in a community.  
Keywords: COVID-19; environmental samples; sewage; wastewater virology; public health 
 
1. Introduction 
Wastewater-based epidemiology (WBE) is an important tool for the surveillance of 
viral diseases at a community level [1]. Studies on the temporal monitoring of enteric vi-
ruses in sewage have shown good correlation between viral titers in samples and local 
registered illnesses and outbreaks [2–4]. Since March 2020, WBE has also been used for 
the surveillance of COVID-19 [5]. Research has shown that the SARS-CoV-2 concentra-
tions in sewage correlates with the number of infection cases and that the virus can be 
detected in wastewater even before the first cases are diagnosed [6].  
However, while WBE represents a powerful tool to monitor the temporal and spatial 
dynamics of viral diseases, the detection of viruses in complex matrices, such as treated 
and untreated wastewater remains challenging. Prior to analysis, RNA viruses in 
wastewater are typically concentrated, followed by the extraction and reverse transcrip-
tion (RT) of RNA and PCR-based quantification, which enables the accurate and sensitive 
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detection of viruses at genus/species/genogroup/genotype/strain level. To date, methods, 
including ultrafiltration, ultracentrifugation, filtration-adsorption, flocculation and poly-
ethylene glycol (PEG) precipitation, commonly used for the detection of enteric viruses 
have been implemented for the detection of SARS-CoV-2 [7,8]. However, in most cases 
the efficiency of these methods for recovering and quantifying enveloped virus concen-
trations have not been assessed. 
This protocol describes an efficient method for the concentration of viruses from 
wastewater and the extraction and quantification of viral RNA, enabling the effective 
monitoring of SARS-CoV-2. The recommended start volume is 100–200 mL of untreated 
wastewater, and the final volume is 0.1 mL. Wastewater concentration starts with a cen-
trifugation step for the elimination of large particulate matter. After pH adjustment, where 
necessary, the supernatant is incubated in a PEG8000/NaCl solution and the viruses bound 
to PEG are pelleted via centrifugation. The resulting pellet is resuspended, and the viral 
RNA is extracted and quantified using a one-step quantitative RT-PCR (qRT-PCR) assay. 
The triplex qRT-PCR described here is suitable for the detection of three targets, including 
the SARS-CoV-2 N1 and E genes and an extraction control, murine norovirus (MNV) or a 
whole process control, the porcine respiratory and reproductive syndrome virus (PRRSV).  
2. Experimental Design 
2.1. Materials 
 PEG8000 (Sigma Aldrich, St. Louis, MO, USA, Cat. No. P5413). 
 NaCl (Sigma Aldrich, St. Louis, MO, USA, Cat. No. S7653). 
 Deionised water or reverse osmosis water with purity ≥18 MΩ resistance. 
 Sterile phosphate buffered saline (PBS), pH 7.4 (Sigma Aldrich, St. Louis, MO, USA, 
Cat. No. P4417). 
 1 M NaOH and 0.5 M HCl for pH adjustment. 
 pH 6.0–10.0 pH strips (VWR, Radnor, PA, USA, Cat No. 85414.601P) or equivalent if 
pH meter is not available. 
 NucliSens lysis buffer (BioMerieux, Marcy-l’Étoile, France, Cat No. 280,134 or 200292). 
 NucliSens extraction reagent kit (BioMerieux, Marcy-l’Étoile, France, Cat. No. 
200293), containing: 
o Magnetic beads mix (Cat No. 280133) 
o Wash Buffer 1 (Cat No. 280130) 
o Wash Buffer 2 (Cat No. 280131) 
o Wash Buffer 3 (Cat No. 280132) 
o Elution Buffer (Cat No. 280132) 
 Elution buffer and Wash Buffer 3 are the same reagents which are aliquoted 
in separate tubes in the extraction reagent kit. 
 Optional control viruses: 
o Whole process control: non-human enveloped virus stock, e.g., PRRSV (Ameri-
can Type Culture Collection (ATCC), Manassas, VA, USA, Cat. No. VR-2385). 
o RNA extraction control: non-human RNA virus stock, e.g., MNV (ATCC, Cat. 
No. VR-1937). 
 RNA UltraSense™ One-Step Quantitative RT-PCR System (Life Technologies, Carls-
bad, CA, USA, Cat. No. 11732927), containing: 
o 5× reaction mix 
o 20× enzyme mix 
o 20× bovine serum albumin (BSA) 
o 50 nM MgSO4 
o ROX reference dye 
 qPCR primers and probes as detailed in Table 1. 
 DNA standards incorporating the target sequences or equivalent: 
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o SARS-CoV-2 N1: 2019-nCoV_N_positive control (Integrated DNA Technologies 
(IDT), Coralville, IA, USA, Cat. No. 10006625) 
o SARS-CoV-2 E: 2019-nCoV_E control (IDT, Coralville, IA, USA, Cat. No. N/A) 
o MNV/PRRSV: custom Ultramer DNA oligo (IDT, Coralville, IA, USA) 
Table 1. Primers, probes and reaction conditions used for the qRT-PCR. MNV: murine norovirus; PRRSV: porcine respir-
atory and reproductive syndrome virus; ORF: open reading frame. 
Target  Primer/Probe  Sequence (5′-3′)  Reference  
SARS-CoV-2 N1 gene region 
Forward primer  GACCCCAAAATCAGCGAAAT  
[9] Reverse primer  TCTGGTTACTGCCAGTTGAATCTG  
Probe 1 [FAM]ACCCCGCATTACGTTTGGTGGACC[MGB]  
SARS-CoV-2 E gene region 
Forward primer  ACAGGTACGTTAATAGTTAATAGCGT 
[10] Reverse primer  ATATTGCAGCAGTACGCACACA 
Probe 1 [VIC]ACACTAGCCATCCTTACTGCGCTTCG[QSY] 
MNV ORF1-2 
Forward primer  CCGCAGGAACGCTCAGCAG  
[11] Reverse primer  GGYTGAATGGGGACGGCCTG  
Probe 1 [ABY]ATGAGTGATGGCGCA[QSY]  
PRRSV ORF7 
Forward primer  CAGGACTTCGGAGCCTCGT 
[12] Reverse primer  AGCAACTGGCACAGTTGATTGA 
Probe 1 [ABY] ACGAGCTGTTAAACGAGGA[QSY] 
1 Probe reporters and quenchers may vary from reference. 
2.2. Equipment 
 Temperature-controlled benchtop centrifuge with fixed-angle rotor and sealed buck-
ets with 50–200 mL tube inserts and capable of speeds up to 10,000× g (Eppendorf, 
Hamburg, Germany). 
 Temperature-controlled benchtop centrifuge with swinging-bucket rotor and sealed 
buckets with 50–200 mL tube inserts and capable of speeds up to 3000× g (Eppendorf, 
Hamburg, Germany). 
 pH meter, pocket size (Ichiro Corporation, Kotoku, Tokyo, Japan, Cat. No. S2K992) 
or equivalent. 
 Microbiological Safety Cabinet (CL2/BSL2 compliant). 
 Vortex mixer. 
 Thermoshaker operating at 60 °C and 1400 rpm or equivalent. 
 Magnetic rack for 1.5 mL tubes. 
 Optional: NucliSens MiniMAG instrument or other (semi-)automated liquid han-
dling system (BioMerieux, Marcy-l’Étoile, France). 
 Optional: aspirator or equivalent apparatus for removing supernatant. 
 Quant Studio Flex 6 real-time PCR machine (Applied Biosystems Inc., Waltham, MA, 
USA) or equivalent (real-time PCR machine with minimum four channels). 
3. Procedure 
The following steps (summarized in Figure 1) can be performed in a Containment 
Level 2 (CL2)/Biosafety Level 2 (BSL2) environment following WHO [13] and national bi-
osafety guidelines. The use of face masks and/or visors is advised during sample concentra-
tion, extraction and quantification preparations to minimize the chance of contamination.  




Figure 1. The stages of the wastewater concentration, RNA extraction and quantification method 
for SARS-CoV-2. 
3.1. Samples and Controls 
 Samples: 100/200 mL untreated wastewater. Samples should be delivered to 
laboratory chilled within 24 h of sampling. Polypropylene bottles are recommended 
for sample collection and shipping. Sample volume can be reduced or increase based 
on the turbidity of the sample. 
 Process negative control: 100/200 mL sterile water. 
 Process positive control: 90/150 mL sterile water spiked with approx. 105 gc PRRSV 
or equivalent. 
 Extraction negative control: 0.5 mL PBS. 
 Extraction positive control: 0.5 mL PBS spiked with approx. 105 gc MNV or equivalent. 
 qRT-PCR non-template control (NTC): 10 µL molecular-grade water. 
3.2. Sample Concentration. Time for Completion: 20–28 h, Bench Time: 1.5 h 
We use a Microbiological Safety Cabinet (CL2/BSL2) to perform steps where the sam-
ple containers and rotors are open. 
1. Aliquot 100/200 mL per wastewater sample into individual 50 mL polypropylene 
centrifuge tubes. Use one negative control in each batch of samples (100–200 mL 
water) and treat as a sample. 
2. Centrifuge samples at 3000× g at 4 °C for 30 min. Alternatively, a 10-min 
centrifugation at 10,000× g at 4 °C can be used. Adjust break speed to 0–5 to avoid 
resuspension of the pellet. 
3. Remove and combine 90/150 mL of the supernatant in a new sterile 250 mL 
polypropylene bottle. Do not disturb the pellet. The volume of liquid may be 
changed, depending on the amount of pellet. Discard pellet. 
4. Optional step: spike supernatant with approx. 105 gc equivalent PRRSV. Spike 90/150 
mL sterile water as well as a positive control. 
5. Adjust the pH of the 90/150 mL supernatant to 7–7.5 (usually up to 1–3 drops of 1 M 
NaOH) to enhance protein binding. 
6. Add 1:3 ratio of 40% PEG 8000, 8% NaCl solution (as described in Section 5) to each 
sample (pH checked) to reach a final concentration of 10% PEG 8000, 2% NaCl. Invert 
several times to mix. 
7. Incubate samples at 4 °C for 14–18 h.  
8. Make a mark on the tube on the side where the pellet will form as it is often difficult 
to see. Alternatively, place the tubes in the centrifuge with label facing up. Keep the 
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tube in same orientation across all centrifuge steps to ensure the pellet builds up in 
the same location. 
9. Centrifuge at 10,000× g for 30 min at 4 °C. Adjust break speed to 0–5 to avoid the 
resuspension of the pellet.  
10. Discard supernatant by decanting and pipetting. 
11. Thoroughly resuspend the pellet in 0.5 mL PBS and proceed with nucleic acid 
extraction or store the concentrate at 4 °C for up to three days, −20° for seven days or 
−80 °C for long term. Alternatively, 2 mL Nuclisens lysis buffer may be added directly 
to the pellet then either extract immediately or store at −80 °C. However, mixing the 
pellet with the buffer may result in excessive foaming.  
3.3. Viral RNA Extraction. Time for Completion: 1.5 h, Bench Time: 1.5 h 
Use a Microbiological Safety Cabinet to perform Steps 1–5.  
1. Optional step: add approx. 105 gc equivalent murine norovirus control to each 
sample. Each day of extractions, include one negative (MNV- 0.5 mL water) and one 
positive control (MNV+ 0.5 mL water spiked with MNV). 
2. Add 2 mL of NucliSens lysis buffer to a 15 mL centrifuge tube. Add 500 µL of sample 
and mix by vortexing (skip this step if lysis buffer was added directly to the pellet in 
step 3.2.10). 
3. Incubate for 10 min at room temperature. 
4. Add 50 µL of well-mixed magnetic bead solution from the extraction kit to the tube 
and mix by vortexing briefly. 
5. Incubate for 10 min at room temperature. 
6. Centrifuge for 2 min at 1500× g then carefully discard supernatant by pipetting or 
aspiration. 
7. Add 385 µL wash buffer 1 and resuspend the pellet by pipetting/vortexing. 
8. Transfer suspension to a 1.5 mL centrifuge tube, vortex for 30 s at low speed and 
separate the beads using a magnetic rack. 
9. Alternatively, when the MiniMag system is used, cut the tube caps off or usescrew-
cap tubes and perform a wash using preset ‘C1 continuous’ or ‘0.5 step’ for 30 s using 
the MiniMAG extraction systems or by vortexing.  
10. After washing, allow silica beads to settle using a magnetic rack or by raising the magnet 
of the MiniMAG extraction system. Discard supernatant by pipetting or aspiration.  
11. Separate tubes from the magnet, then add 385 µL Wash Buffer 1. Resuspend the 
pellet, wash for 30 sec (Step 8 or 9), allow silica beads to settle using the magnet then 
discard supernatant. 
12. Separate tubes from the magnet, then add 485 µL Wash Buffer 2. Resuspend pellet, 
wash for 30 s (Step 8 or 9), allow silica beads to settle using magnet then discard 
supernatant. Repeat. 
13. Separate tubes from magnet, then add 500 µL Wash Buffer 3. Wash for 15 s (step 8), 
allow silica beads to settle using magnet then discard supernatant. 
Note: samples should not be left in Wash Buffer 3 for longer than strictly necessary. 
14. Add 100 µL elution buffer. Cap tubes and transfer to thermoshaker or equivalent. 
15. Incubate for 5 min at 60 °C with shaking at 1400 rpm. 
16. Place tubes in magnetic rack and allow silica beads to settle, then transfer eluate to a 
clean, labelled 0.5 mL tube. Continue to qRT-PCR or store the extracts at −80 °C. 
3.4. qRT-PCR Quantification of Viral Genome Copies. Time for Completion: 4.5 h, Bench Time: 
1–1.5 h 
1. Prepare and aliquot primer and probe mixes to avoid repeated freezing/thawing.  
2. Prepare qRT-PCR master mix as described in Table 2. Each sample should be run in 
duplicate. Duplicates of standard dilution series (at least five points in the concentration 
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range of 106–100 gc/µL) and of a no template control (NTC) consisting of molecular 
biology grade water or Tris-EDTA (TE) buffer should be included in each run. 
3. Use run conditions described in Table 3 for the one-step qRT-PCR reaction. 
Table 2. qRT-PCR reaction mix. Primer/probe mix compositions are detailed in Section 5. 
Reagent Concentration μL/Reaction Mix 
Water, molecular grade - 8.35 
Reaction mix 5× 5 
Enzyme mix 20× 1.25 
Bovine serum albumin (BSA) 20× 1.25 
MgSO4 50 mM 0.4 
Primer/probe mix, N1 5–20 µM 1.25 
Primer/probe mix, E 5–20 µM 1.25 
Primer/probe mix, MNV or PRRSV 5–20 µM 1.25 
Sample/NTC/standard - 5 
Sum  25 
Table 3. qRT-PCR run conditions. 
Temperature Time Number of Cycles 
55 °C 60 min 1 
95 °C 5 min 1 
95 °C 15 s 
45 60 °C 1 min 
65 °C 1 min * 
* Data collection. 
3.5. Data Analysis 
SARS-CoV-2 concentrations should be calculated as: 
N1 or E gene/mL wastewater = gc number in qRT-PCR reaction × 20/sample supernatant volume in mL (1)
MNV/PRRSV recoveries should be calculated as: 
Recovery % = gc in sample/gc in positive control × 100 (2)
Quality control: 
 Process negative control, extraction negative control and NTC should be negative 
for all gene targets.  
 qRT-PCR standard curve should be in line with the recommendations described in 
The MIQE Guidelines [14]. 
 Ct values > 40 should be considered negative. We rcommend using 45 cycles of 
amplification to assess the amplification curve for samples with Ct values of 38–40. 
 Control virus recovery should exceed 1%, as suggested by previous standard 
method for viral detection in shellfish (ISO 15216-2:2019). When viral recovery is 
lower than 1%, the qRT-PCR should be repeated with 2 µL samples added to the 
reaction mix to assess potential inhibition. 
4. Expected Results 
4.1. Method Efficiency 
We have tested the limit of detection (LOD) and limit of quantification (LOQ) of the 
triplex assay targeting the SARS-CoV-2 N1 and E genes and the MNV by spiking 
wastewater extracts with viral RNA with nominal concentrations of approx. 100, 50, 20, 
10, 5 and 2 gc/µL. Replicates of ten of each dilution were then tested and quantified using 
a dilution series of DNA standards. The LOD was determined as the lowest concentration 
where all ten replicates were positive. LOQ was determined as the lowest concentration 
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where the coefficient of variance was below 0.25. LOD and LOQ values are summarized 
in Table 4. Our preliminary results showed that the multiplexing had no significant effect 
on the amplification (Figure S1). 
Table 4. Limit of detection (LOD) and limit of quantification (LOQ) for the triplex qRT-PCR assay 









gc/μL RNA Extract 
SARS-CoV-2 N1 9 1.7 59 11.8 
SARS-CoV-2 E  19 3.8 126 25.1 
MNV 16 3.1 164 32.1 
To assess process efficiency, we spiked 90 mL of three wastewater sample superna-
tants after the initial centrifugation step in duplicates/triplicates with 3.0 × 105 gc PRRSV 
and concentrated the samples as described above. The samples are taken at different 
wastewater treatment plants in the UK and labelled as D, L and M for anonymity (Table 
5). The concentrates were spiked with 1.9 × 105 gc MNV and the samples were then ex-
tracted, and viral RNA was quantified. Results are summarized in Table 5. No contami-
nation in any of the negative controls were found and no qRT-PCR inhibition was ob-
served. Based on the recovery rates, the concentration and subsequent extract methods 
are reproduceable and reliable for the detection of the target sequences. However, recov-
ery rates (Table 5) may vary based on the physico-chemical properties of the wastewater 
samples, and hence the viral concentration efficiency should be monitored. 
Table 5. Viral recovery in wastewater supernatant spiked with reproductive syndrome virus 
(PRRSV) and concentrates spiked with murine norovirus (MNV). 
Wastewater Sample PRRSV Recovery % MNV Recovery % N1 Gene Sewage E gene Sewage 
D1 55.94 37.31 detected detected 
D2 31.52 32.05 detected detected 
L1 3.34 11.45 detected not detected 
L2 3.86 17.15 not detected detected 
L3 3.97 9.70 detected detected 
M1 9.81 16.43 not detected not detected 
M2 5.58 16.56 not detected not detected 
M3 3.41 13.21 not detected not detected 
4.2. Applications and Recommendations 
Precipitation using PEG is a widely used method for the capture and concentration 
of RNA, DNA, and viruses including the pelleting of enteric DNA and RNA viruses [3,15], 
human coronaviruses [16,17], including SARS-CoV-2 [18] in wastewater and in other en-
vironmental samples. Previous studies where wastewater was spiked with murine hepa-
titis virus (an enveloped coronavirus surrogate) suggested that PEG precipitation results 
in up to 73% viral recovery [19,20]. However, while most published studies recommend 
PEG incubation times of 2–4 h at 4 °C, the longer, overnight incubation enhances the re-
covery of RNA [21], and hence decayed viral fragments can be recovered. This may be 
beneficial for wastewater-based epidemiology, where the infectivity state of the detected 
viruses is not relevant. 
We have tested this method with several 100 mL and 200 mL wastewater samples, 
however, the starting volume can be easily changed by adjusting the volume of the 
PEG8000 solution. We have not detected qRT-PCR inhibition. However, inhibition should 
be assessed when the recovery of control viruses is unsatisfactory.  
We recommend the complete spatial separation of concentration, RNA extraction 
and quantification using separate biosafety cabinets and/or rooms to perform each stage. 
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The use of face masks and shields in addition to biosafety cabinets is also recommended 
as staff members may be asymptomatic carriers of COVID-19. 
The qRT-PCR method described here was optimized using the QuantStudio real-time 
system. When different equipment is used, the probe dyes may need to be altered. In that 
case, we recommend the validation of the assay and the determination of LOD/LOQ val-
ues as described in Section 4.1. 
5. Reagents Setup 
40% PEG 8000, 8% NaCl solution 
PEG 8000: 400 g; 
NaCl: 80 g; 
Deionised water: 1000 mL; 
Mix 100 g PEG 8000 with 800 mL water and mix on a magnetic stirrer until dissolved. 
Continue adding PEG 8000 in small portions until 400 g is added. Once the PEG 8000 dis-
solved, add 80 g NaCl mix until dissolved and top the solution up to 1000 mL. Autoclave 
solution to sterilize (30 min, 121 °C) and keep at room temperature for up to 12 months. 
Primer/probe mixes 
Forward primer, 100 µM: 100 µL; 
Reverse primer, 100 µM: 200 µL; 
Probe, 100 µM: 50 µL; 
Molecular-grade water: 650 µL; 
Custom-made primers and probes should be resuspended in molecular grade water 
if necessary, according to the manufacturer’s instructions to reach 100 µM concentration. 
Primers, probes and mixes should be stored at −20 °C and completely thawed before use. 
Mixes should be aliquoted to small portions to avoid repeated freezing-thawing. 
Supplementary Materials: The following are available online at www.mdpi.com/2409-
9279/4/1/17/s1, Figure S1: amplification curves observed for the (A) N1 (singleplex: yellow curves, 
triplex: light green curves), (B) E (singleplex: red curves, triplex: light green curves) and (C) MNV 
(singleplex: green curves, triplex: light green curves). 
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